Numinus has received Health Canada approval to conduct a clinical trial to test the effects of MDMA, the amphetamine more commonly known as ecstasy, in the treatment of patients suffering from severe post-traumatic stress disorder.
Organization: Numinus Wellness
The Short Report – March 10, 2021: Federal funding for applied genomics, investments in plant-based proteins, the death of a renowned Alberta ecologist, and more
The Government of Canada invests $8.6 million towards applied genomics research with another $17.8 million from its partners, Protein Industries Canada funds three plant-based protein projects, the death of renowned Alberta ecologist Dr. David Schindler, and more.